Timothy M Pawlik

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Disclosure of "nonharmful" medical errors and other events: duty to disclose
    Catherine J Chamberlain
    Department of Surgery, School of Medicine, The Johns Hopkins University, Harvey Room 611, 600 N Wolfe St, Baltimore, MD 21287, USA
    Arch Surg 147:282-6. 2012
  2. ncbi Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension
    David L Joyce
    Departments of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 22187 6681, USA
    World J Surg Oncol 6:80. 2008
  3. ncbi Primary sclerosing cholangitis: role of extrahepatic biliary resection
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins University Hospital, Baltimore, MD 21287, USA
    J Am Coll Surg 206:822-30; discussion 830-2. 2008
  4. ncbi Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Ann Surg 245:435-42. 2007
  5. ncbi Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 11:1478-86; discussion 1486-7. 2007
  6. ncbi Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 14:2807-16. 2007
  7. ncbi The role of radiation in retroperitoneal sarcomas: a surgical perspective
    Timothy M Pawlik
    Department of Surgery, Division of Surgical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Curr Opin Oncol 19:359-66. 2007
  8. ncbi Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
    Timothy M Pawlik
    Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Surgery 141:610-8. 2007
  9. ncbi Debate: Resection for early hepatocellular carcinoma
    Timothy M Pawlik
    Departments of Surgery, Johns Hopkins School of Medicine, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 13:1026-8. 2009
  10. ncbi Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M, d, Anderson Cancer Center, Houston, Texas, USA
    BMC Cancer 6:68. 2006

Detail Information

Publications126 found, 100 shown here

  1. ncbi Disclosure of "nonharmful" medical errors and other events: duty to disclose
    Catherine J Chamberlain
    Department of Surgery, School of Medicine, The Johns Hopkins University, Harvey Room 611, 600 N Wolfe St, Baltimore, MD 21287, USA
    Arch Surg 147:282-6. 2012
    ..Full disclosure of nonharmful errors is advocated, and recommendations on how to discuss errors with patients are provided. An argument that full error disclosure may improve future patient care is also outlined...
  2. ncbi Multi-visceral resection of pancreatic VIPoma in a patient with sinistral portal hypertension
    David L Joyce
    Departments of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 22187 6681, USA
    World J Surg Oncol 6:80. 2008
    ..VIPomas are rare neuroendocrine tumors poorly described in the literature. Aggressive resection of patients with advanced VIPoma neuroendocrine tumors has rarely been reported...
  3. ncbi Primary sclerosing cholangitis: role of extrahepatic biliary resection
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins University Hospital, Baltimore, MD 21287, USA
    J Am Coll Surg 206:822-30; discussion 830-2. 2008
    ..Management of PSC patients without cirrhosis remains controversial. We examined the results of extrahepatic biliary resection (EHBR) for PSC...
  4. ncbi Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Ann Surg 245:435-42. 2007
    ..To examine the diagnostic agreement of preoperative needle core biopsy (NCB) grading of hepatocellular carcinoma (HCC) compared with the final surgical pathologic tumor grade...
  5. ncbi Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 11:1478-86; discussion 1486-7. 2007
    ....
  6. ncbi Liver-directed surgery for metastatic squamous cell carcinoma to the liver: results of a multi-center analysis
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 14:2807-16. 2007
    ..The role of hepatic resection for metastatic squamous cell carcinoma (SCC) remains unknown. The current study evaluates the role of hepatic resection in patients with metastatic SCC to the liver...
  7. ncbi The role of radiation in retroperitoneal sarcomas: a surgical perspective
    Timothy M Pawlik
    Department of Surgery, Division of Surgical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Curr Opin Oncol 19:359-66. 2007
    ..Although data suggest that the addition of intraoperative radiation therapy to external beam radiation therapy improves local control, intraoperative radiation therapy may be related to additional toxicity...
  8. ncbi Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer
    Timothy M Pawlik
    Department of Surgery, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD 22187 6681, USA
    Surgery 141:610-8. 2007
    ....
  9. ncbi Debate: Resection for early hepatocellular carcinoma
    Timothy M Pawlik
    Departments of Surgery, Johns Hopkins School of Medicine, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 13:1026-8. 2009
    ..The best therapeutic strategies for patients with early HCC and well-compensated cirrhosis should be dependent on the individual clinical situation, not adherence to dogmatic universal adoption of either resection or transplantation...
  10. ncbi Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M, d, Anderson Cancer Center, Houston, Texas, USA
    BMC Cancer 6:68. 2006
    ....
  11. ncbi Expanding criteria for resectability of colorectal liver metastases
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 22187 6681, USA
    Oncologist 13:51-64. 2008
    ..A therapeutic approach that includes all aspects of multidisciplinary and multimodality care is required to select and treat this complex group of patients...
  12. ncbi Patient readmission and mortality after surgery for hepato-pancreato-biliary malignancies
    Eric B Schneider
    Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD
    J Am Coll Surg 215:607-15. 2012
    ..The objective of the current study was to compare readmission after pancreatic vs hepatobiliary surgical procedures, as well as to identify potential factors associated with higher readmission within 30 days of discharge...
  13. ncbi Liver-directed therapy for hepatic metastases in patients undergoing pancreaticoduodenectomy: a dual-center analysis
    Mechteld C de Jong
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 252:142-8. 2010
    ..To analyze the perioperative and long-term outcomes of patients undergoing liver-directed therapy after pancreaticoduodenectomy in a large dual-center cohort of patients...
  14. ncbi Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas
    Michael J Swartz
    Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 2410, USA
    Int J Radiat Oncol Biol Phys 76:839-44. 2010
    ..Intraductal papillary mucinous neoplasms are mucin-producing cystic neoplasms of the pancreas. One-third are associated with invasive carcinoma. We examined the benefit of adjuvant chemoradiotherapy (CRT) for this cohort...
  15. ncbi The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases
    Mechteld C de Jong
    Division of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Cancer 118:4737-47. 2012
    ..In this study, the authors sought to identify factors associated with outcome after surgical management of hilar cholangiocarcinoma and examined the impact of PVR on survival...
  16. ncbi Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases
    Daria Zorzi
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
    J Gastrointest Surg 10:86-94. 2006
    ..AR is not superior to WR in terms of tumor clearance, pattern of recurrence, or survival. WR should remain an integral component of the surgical treatment of CLM...
  17. ncbi Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors
    Eric B Schneider
    Department of Surgery and Center for Surgical Trials and Outcomes Research, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Am Coll Surg 214:390-8; discussion 398-9. 2012
    ..The objective of the current study was to evaluate risk factors associated with readmission among a nationwide cohort of patients after colorectal surgery...
  18. ncbi Adjuvant chemoradiation for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Charles C Hsu
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins Hospital, Baltimore, MD, USA
    Ann Surg Oncol 17:981-90. 2010
    ..Our goal was to examine efficacy of adjuvant CRT in resected pancreatic adenocarcinoma compared with surgery alone...
  19. ncbi Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-flurouracil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio
    Bolanle Asiyanbola
    Department of Surgery, Johns Hopkins Hospital, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 13:752-9. 2009
    ..There are limited data on patterns of recurrence and factors associated with local recurrence following pancreaticoduodenectomy for pancreatic adenocarcinoma and adjuvant 5-flurouracil-based chemoradiation therapy...
  20. ncbi Trends in nontherapeutic laparotomy rates in patients undergoing surgical therapy for hepatic colorectal metastases
    Timothy M Pawlik
    Department of Surgery, The Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, MD 22187, USA
    Ann Surg Oncol 16:371-8. 2009
    ..The reasons for this trend are probably multifactorial and may include improved preoperative assessment, such as PET imaging, as well as salvage surgical options...
  21. ncbi Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients
    Hari Nathan
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Am Coll Surg 210:755-64, 764-6. 2010
    ..We sought to assess the comparative performance of various colorectal liver metastasis prognostic scoring systems, as well as to investigate the CS of patients who underwent resection of colorectal liver metastasis...
  22. ncbi Incidence and management of chyle leaks following pancreatic resection: a high volume single-center institutional experience
    Lia Assumpcao
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 12:1915-23. 2008
    ..We sought to identify possible risk factors associated with chyle leaks following pancreatic resection, as well as determine the natural history of this rare complication...
  23. ncbi Early mortality risk score: identification of poor outcomes following upfront surgery for resectable pancreatic cancer
    Charles C Hsu
    The Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, 410 North Broadway Suite 1440, Baltimore, MD 21231 2410, USA
    J Gastrointest Surg 16:753-61. 2012
    ..This study examines the preoperative predictors of early mortality following PD and combines these variables into an early mortality risk score (EMRS)...
  24. ncbi Therapeutic efficacy of combined intraoperative ablation and resection for colorectal liver metastases: an international, multi-institutional analysis
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Harvey 611, 600N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 15:336-44. 2011
    ..By combining resection and ablation, the number of patients eligible for surgery can be expanded. We sought to determine the efficacy of combined resection and ablation for CRLM...
  25. ncbi Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 444, Houston 77030, USA
    Ann Surg Oncol 13:712-20. 2006
    ..Resection should be performed as part of a multidisciplinary approach, because recurrence is common...
  26. ncbi Resection of hepatic colorectal metastases involving the caudate lobe: perioperative outcome and survival
    Eddie K Abdalla
    Department of Surgical Oncology Unit 444, University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1402, USA
    J Gastrointest Surg 11:66-72. 2007
    ..To examine clinical features and outcome of patients who underwent hepatic resection for colorectal liver metastases (LM) involving the caudate lobe...
  27. ncbi Adjuvant chemoradiation therapy after pancreaticoduodenectomy in elderly patients with pancreatic adenocarcinoma
    David P Horowitz
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 80:1391-7. 2011
    ..To evaluate the efficacy of adjuvant chemoradiation therapy (CRT) for pancreatic adenocarcinoma patients ≥ 75 years of age...
  28. ncbi Two-stage strategy for patients with extensive bilateral colorectal liver metastases
    Susan Tsai
    Department of Surgery, Division of Surgical Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    HPB (Oxford) 12:262-9. 2010
    ..Two-stage hepatectomy has been proposed for patients with bilateral colorectal liver metastases. The present study assesses the feasibility and outcome of two-stage hepatectomy for the treatment of colorectal liver metastases...
  29. ncbi Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma
    Timothy M Pawlik
    Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX 77230, USA
    Liver Transpl 11:1086-92. 2005
    ....
  30. ncbi Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study
    Susan Tsai
    Department of Surgery, Johns Hopkins Medical Institutions, 600N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 14:1143-50. 2010
    ..To examine the effect of body mass index (BMI) on clinicopathologic factors and long-term survival in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma...
  31. ncbi Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series
    Sushanth Reddy
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA
    J Am Coll Surg 208:950-7; discussion 957-9. 2009
    ..Solid-pseudopapillary neoplasms (SPNs) are rare pancreatic tumors with malignant potential. Clinicopathologic characteristics and outcomes of patients with SPN were reviewed...
  32. ncbi Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis
    Srinevas K Reddy
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Ann Surg Oncol 16:1809-19. 2009
    ..However, prospective randomized trials are needed to determine the optimal timing of chemotherapy...
  33. ncbi Outcomes of adjuvant chemoradiation after pancreaticoduodenectomy with mesenterico-portal vein resection for adenocarcinoma of the pancreas
    Boris Hristov
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University, Baltimore, MD, USA
    Int J Radiat Oncol Biol Phys 76:176-80. 2010
    ..The purpose of this study was to compare outcomes between pancreaticoduodenectomy (PD) with and without mesenterico-portal vein resection (VR) in patients receiving adjuvant CRT for pancreatic adenocarcinoma...
  34. ncbi Sequential intra-arterial therapy and portal vein embolization is feasible and safe in patients with advanced hepatic malignancies
    Peter D Peng
    Department of Surgery, Johns Hopkins Hospital, Baltimore, MD, USA
    HPB (Oxford) 14:523-31. 2012
    ..Portal vein embolization (PVE) with intra-arterial therapy (IAT) may increase future liver remnant (FLR) hypertrophy. As such, the feasibility, safety and efficacy of IAT+PVE were investigated...
  35. ncbi Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis
    Jordan M Winter
    Department of Surgery, Johns Hopkins Medical Institutions, Halsted 610, 600 N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 14:379-87. 2010
    ..We sought to examine the outcome of patients undergoing pancreaticoduodenectomy versus ampullectomy, as well as to identify factors predictive of lymph node metastasis in patients with ampullary neoplasms...
  36. ncbi Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 250:440-8. 2009
    ..To investigate rates and patterns of recurrence in patients following curative intent surgery for colorectal liver metastasis...
  37. ncbi Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis
    Srinevas K Reddy
    Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
    Ann Surg Oncol 14:3481-91. 2007
    ..This multi-institutional retrospective study compared postoperative outcomes after simultaneous and staged colorectal and hepatic resections...
  38. ncbi Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma
    Timothy M Pawlik
    Department of Surgery, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA
    Arch Surg 140:450-7; discussion 457-8. 2005
    ..Clinical predictors should not be used to exclude patients from surgical resection because these factors do not reliably predict outcome...
  39. ncbi Oncolysis by viral replication and inhibition of angiogenesis by a replication-conditional herpes simplex virus that expresses mouse endostatin
    John T Mullen
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Cancer 101:869-77. 2004
    ..CONCLUSIONS: The oncolytic HSV-1 mutant HSV-Endo provided a two-pronged therapy; namely, inhibition of angiogenesis and direct tumor cell destruction by viral replication...
  40. ncbi Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study
    Timothy M Pawlik
    Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Surgery 137:403-10. 2005
    ..Patients with HCC and major vascular invasion who derive long-term benefit from resection have no or minimal underlying fibrosis...
  41. ncbi The role of liver-directed surgery in patients with hepatic metastasis from a gynecologic primary carcinoma
    Sarah I Kamel
    Department of Surgery, Johns Hopkins University School of Medicine, Harvey 611, 600 N Wolfe Street, Baltimore, MD 21287, USA
    World J Surg 35:1345-54. 2011
    ..We sought to determine the safety and efficacy of liver-directed surgery for hepatic metastasis from gynecologic primaries...
  42. ncbi Re-evaluating the impact of tumor size on survival following pancreaticoduodenectomy for pancreatic adenocarcinoma
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    J Surg Oncol 103:656-62. 2011
    ..We sought to examine the association of size with outcomes following resection of pancreatic adenocarcinoma...
  43. ncbi Variation in lymph node assessment after colon cancer resection: patient, surgeon, pathologist, or hospital?
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 15:471-9. 2011
    ..We sought to quantify relative proportions of the variation in lymph node assessment after colon cancer resection occurring at the patient, surgeon, pathologist, and hospital levels...
  44. ncbi National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis
    Skye C Mayo
    Department of Surgery, The Johns Hopkins University School of Medicine, Harvey 611, 600 N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 14:1578-91. 2010
    ..We sought to evaluate compliance with these recommendations and to assess trends in the management and survival of patients with GBA...
  45. ncbi Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA
    J Surg Oncol 102:256-63. 2010
    ..The management of patients with peri-ampullary liver metastasis remains controversial. We sought to assess the safety and efficacy of curative intent surgery for peri-ampullary liver metastasis...
  46. ncbi Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma
    Peter Peng
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 16:1478-86. 2012
    ..Sarcopenia--the measurement of muscle wasting--may be a more objective and comprehensive patient-specific factor associated with long-term survival...
  47. ncbi Hepatic resection for metastatic gastrointestinal stromal tumors in the tyrosine kinase inhibitor era
    Ryan S Turley
    Department of Surgery, Duke University Medical Center, Durham, NC 27110, USA
    Cancer 118:3571-8. 2012
    ..The objective of this study was to determine whether combination therapy for hepatic GIST metastases is associated with improved overall survival compared with reported outcomes from surgery or TKI therapy alone...
  48. ncbi Conditional survival in patients with pancreatic ductal adenocarcinoma resected with curative intent
    Skye C Mayo
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer 118:2674-81. 2012
    ..Survival estimates, however, are dynamic and may change based on the time already survived. The authors sought to assess conditional survival among a large cohort of patients who underwent resection of PDAC...
  49. ncbi National trends in surgical procedures for hepatocellular carcinoma: 1998-2008
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Cancer 118:1838-44. 2012
    ..We quantified trends in use, mortality, and patient and hospital characteristics for 3 surgical therapies for HCC (resection, ablation, and transplantation) in the United States from 1998 to 2008...
  50. ncbi Palliative surgical management of patients with unresectable pancreatic adenocarcinoma: trends and lessons learned from a large, single institution experience
    Peter J Kneuertz
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Gastrointest Surg 15:1917-27. 2011
    ..We examined trends in the relative use of palliative bypass over time with an emphasis on identifying changes in surgical indications, type of bypass performed, as well as perioperative outcomes associated with surgical palliation...
  51. ncbi Adjuvant chemoradiation therapy for adenocarcinoma of the distal pancreas
    Kristin J Redmond
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 17:3112-9. 2010
    ..This study was designed to examine the effect of adjuvant 5-FU-based chemoradiation therapy (CRT) after distal pancreatectomy for adenocarcinoma of the distal pancreas...
  52. ncbi Pancreatic resection of isolated metastases from nonpancreatic primary cancers
    Sushanth Reddy
    Department of Surgery, The Johns Hopkins University, 600 North Wolfe Street, Carnegie 681, Baltimore, Maryland 21287, USA
    Ann Surg Oncol 15:3199-206. 2008
    ..The goal of this study is to report the safety and efficacy of pancreatic resection for isolated metastatic cancers from nonpancreatic primary disease...
  53. ncbi Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Surg Oncol 99:87-92. 2009
    ..We sought to analyze peri-operative mortality and long-term survival following TP versus PP for pancreatic adenocarcinoma...
  54. ncbi Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis
    Mark B Slidell
    Department of Surgery, Georgetown University Hospital, Washington, District of Columbia, USA
    Ann Surg Oncol 15:165-74. 2008
    ..LNR has never been investigated in a large population-based study of patients with pancreatic adenocarcinoma...
  55. ncbi Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival
    Sushanth Reddy
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 22187, USA
    Ann Surg 250:282-7. 2009
    ..To analyze relative perioperative and long-term outcomes of patients undergoing total pancreatectomy versus pancreaticoduodenectomy...
  56. ncbi Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified?
    Ana Luiza Gleisner
    Department of Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, Baltimore, Maryland 22187 6681, USA
    Cancer 110:2484-92. 2007
    ..Specifically, the role of hepatic resection for metastatic periampullary or pancreatic adenocarcinoma remains controversial...
  57. ncbi Selectivity of an oncolytic herpes simplex virus for cells expressing the DF3/MUC1 antigen
    Hideki Kasuya
    Division of Surgical Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Cancer Res 64:2561-7. 2004
    ..DF3gamma34.5 was effective against carcinoma xenografts in nude mice. Regulation of gamma(1)34.5 by the DF3/MUC1 promoter is a promising strategy for development of HSV-1 mutants for viral oncolysis...
  58. ncbi Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Harvey 611 600 N Wolfe Street, Baltimore, MD 21287, USA
    J Gastrointest Surg 13:2141-51. 2009
    ..We sought to determine safety and efficacy of repeat CIS for recurrent colorectal liver metastasis as well as determine factors predictive of survival in a large multicenter cohort of patients...
  59. ncbi Predictors of survival after resection of retroperitoneal sarcoma: a population-based analysis and critical appraisal of the AJCC staging system
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg 250:970-6. 2009
    ..To identify predictors of survival after resection of retroperitoneal sarcoma (RPS) and to evaluate the performance of the American Joint Committee on Cancer (AJCC) staging system for RPS...
  60. ncbi Management of patients with pancreatic adenocarcinoma: national trends in patient selection, operative management, and use of adjuvant therapy
    Skye C Mayo
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Am Coll Surg 214:33-45. 2012
    ..Advances in surgical technique and perioperative care have reduced perioperative mortality; however, temporal trends in perioperative morbidity and the use of adjuvant therapy on a population basis remain ill-defined...
  61. ncbi Evaluation of adjuvant chemoradiation therapy for ampullary adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study
    Amol K Narang
    Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Radiat Oncol 6:126. 2011
    ..We combined the experience of two institutions to better delineate which patients may benefit from adjuvant chemoradiation...
  62. ncbi Refining the definition of perioperative mortality following hepatectomy using death within 90 days as the standard criterion
    Skye C Mayo
    Department of Surgery, School of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
    HPB (Oxford) 13:473-82. 2011
    ..To better define perioperative mortality, trends in the risk for death during the first 90 days after hepatectomy were assessed...
  63. ncbi Subtotal hepatectomy following neoadjuvant chemotherapy for a previously unresectable hepatocellular carcinoma
    Daria Zorzi
    Department of Surgical Oncology, Unit 444, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, 77030-4009, USA
    J Hepatobiliary Pancreat Surg 13:347-50. 2006
    ..This case illustrates that the combination of innovative neoadjuvant chemotherapy and well-planned surgical approaches may benefit a small number of patients previously deemed unresectable...
  64. ncbi Intrahepatic cholangiocarcinoma
    George A Poultsides
    Department of Surgery, Division of Surgical Oncology, Stanford University School of Medicine, 300 Pasteur Drive, H3680, Stanford, CA 94305 5641, USA
    Surg Clin North Am 90:817-37. 2010
    ..For those patients with inoperable disease, locoregional therapy with transarterial chemoembolization can be considered...
  65. ncbi Debunking dogma: surgery for four or more colorectal liver metastases is justified
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Gastrointest Surg 10:240-8. 2006
    ..Certain clinicopathologic factors, including lack of response to neoadjuvant chemotherapy, were associated with a worse prognosis...
  66. ncbi Colorectal liver metastases: recurrence and survival following hepatic resection, radiofrequency ablation, and combined resection-radiofrequency ablation
    Ana L Gleisner
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 22187 6681, USA
    Arch Surg 143:1204-12. 2008
    ....
  67. ncbi Solitary colorectal liver metastasis: resection determines outcome
    Thomas A Aloia
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77230-1402, USA
    Arch Surg 141:460-6; discussion 466-7. 2006
    ..Every method should be considered to achieve resection of solitary colorectal liver metastasis, including referral to a specialty center, extended hepatectomy, and chemotherapy...
  68. ncbi A proposed staging system for intrahepatic cholangiocarcinoma
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 16:14-22. 2009
    ..We propose a staging system specifically developed for ICC based on number of tumors, vascular invasion, lymph node status, and presence of metastatic disease...
  69. ncbi Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Surg 141:537-43; discussion 543-4. 2006
    ..Patients with sarcoma liver metastasis should be evaluated by a multidisciplinary team, as recurrence is common and adjuvant therapy may prolong survival...
  70. ncbi Patterns of recurrence following liver resection for colorectal metastases: effect of primary rectal tumor site
    Lia Assumpcao
    Department of Surgery, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA
    Arch Surg 143:743-9; discussion 749-50. 2008
    ..This may affect the pattern of recurrence and survival rates following hepatic resection of liver metastases from rectal adenocarcinoma...
  71. ncbi Hilar cholangiocarcinoma: tumor depth as a predictor of outcome
    Mechteld C de Jong
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Arch Surg 146:697-703. 2011
    ..The American Joint Committee on Cancer staging system for hilar cholangiocarcinoma may be inaccurate because the bile duct lacks discrete tissue boundaries...
  72. ncbi Surgical management of early-stage hepatocellular carcinoma: resection or transplantation?
    Emily C Bellavance
    Department of Surgery, University of Maryland Medical Center, Baltimore, MD, USA
    J Gastrointest Surg 12:1699-708. 2008
    ..The purpose of the current study was to compare the outcome of patients with well-compensated cirrhosis and early stage hepatocellular carcinoma treated with initial hepatic resection versus transplantation...
  73. ncbi Shifting trends in liver-directed management of patients with colorectal liver metastasis: a population-based analysis
    Skye C Mayo
    Department of Surgery, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21287, USA
    Surgery 150:204-16. 2011
    ..We sought to evaluate population-based temporal trends in perioperative management, as well as short- and long-term outcomes associated with the operative management of colorectal liver metastasis (CRLM)...
  74. ncbi Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients
    K Ranh Voong
    Department of Radiation Oncology and Molecular Radiation Sciences, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD 21231 6681, USA
    Hum Pathol 41:113-22. 2010
    ..Treatment with adjuvant chemoradiation therapy is associated with improved survival. The proportion of squamous differentiation in resected pancreatic adenosquamous carcinoma specimens does not appear to impact overall survival...
  75. ncbi Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment
    Mechteld C de Jong
    Johns Hopkins University School of Medicine, Baltimore, MD, USA
    J Clin Oncol 29:3140-5. 2011
    ..To identify factors associated with outcome after surgical management of intrahepatic cholangiocarcinoma (ICC) and examine the impact of lymph node (LN) assessment on survival...
  76. ncbi Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis
    Skye C Mayo
    Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Ann Surg Oncol 17:3129-36. 2010
    ..We sought to define the efficacy of the surgical management of NELM in a large multicenter international cohort of patients...
  77. ncbi Risk factors for pancreatic leak after distal pancreatectomy
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    Ann Surg 250:277-81. 2009
    ..We sought to evaluate the incidence of and identify risk factors for the development of PL in patients undergoing distal pancreatectomy (DP) at a single high-volume institution...
  78. ncbi Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, 77230, USA
    Cancer 106:900-6. 2006
    ..Whereas the treatment approach for patients with mixed DM should be similar to that of other melanoma patients, patients with pure DM are unlikely to have metastatic disease in regional lymph nodes and SLNB may not be warranted...
  79. ncbi The effect of steatosis on echogenicity of colorectal liver metastases on intraoperative ultrasonography
    Mark G Van Vledder
    Department of Surgery, The Johns Hopkins Hospital, The Johns Hopkins University School of Medicine, 600 N Wolfe Street, Baltimore, MD 21287, USA
    Arch Surg 145:661-7. 2010
    ..To investigate the association of relative tumor echogenicity and hepatic steatosis in patients undergoing resection of colorectal liver metastases (CRLM)...
  80. ncbi Patient variability in intraoperative ultrasonographic characteristics of colorectal liver metastases
    Michael A Choti
    Department of Surgery, Johns Hopkins Hospital, 600 N Wolfe St, Blalock 665, Baltimore, MD 22187 6681, USA
    Arch Surg 143:29-34; discussion 35. 2008
    ..The interpatient and intrapatient variability of tumor IOUS echogenicity was assessed...
  81. ncbi Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas
    George A Poultsides
    Department of Surgery, Sidney Kimmel Cancer Center, Johns Hopkins Hospital, Baltimore, MD, USA
    Ann Surg 251:470-6. 2010
    ....
  82. ncbi Predictors and natural history of in-transit melanoma after sentinel lymphadenectomy
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 444, PO Box 301402, Houston, Texas 77230-1402, USA
    Ann Surg Oncol 12:587-96. 2005
    ..In-transit recurrence, as well as subsequent distant metastatic failure, can be predicted on the basis of adverse tumor factors and SLN status...
  83. ncbi Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Room 442, Cancer Research Building, 1650 Orleans Street, Baltimore, MD 21231 1000, USA
    J Gastrointest Surg 11:1488-96; discussion 1496-7. 2007
    ..We suggest that these trends are largely caused by developments in imaging technology, improvements in patient selection, and advances in surgical techniques...
  84. ncbi Racial disparity in surgical mortality after major hepatectomy
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Am Coll Surg 207:312-9. 2008
    ..We sought to quantify and explore the nature of racial disparities in surgical mortality after major hepatectomy in a nationally representative cohort of patients...
  85. ncbi Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital
    Joseph M Herman
    Department of Radiation Oncology and Molecular Radiation Sciences, Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins Hospital, Baltimore, MD, USA
    J Clin Oncol 26:3503-10. 2008
    ..To examine the efficacy of adjuvant chemoradiotherapy after pancreaticoduodenectomy (PD) for pancreatic adenocarcinoma (PC) in patients undergoing resection at Johns Hopkins Hospital (JHH; Baltimore, MD)...
  86. ncbi Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg 241:715-22, discussion 722-4. 2005
    ..A predicted margin of <1 cm after resection of hepatic colorectal metastases should not be used as an exclusion criterion for resection...
  87. ncbi Regulation of herpes simplex virus 1 replication using tumor-associated promoters
    John T Mullen
    Division of Surgical Oncology, Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA
    Ann Surg 236:502-12; discussion 512-3. 2002
    ..Because of its preferential replication in MUC1-positive tumors, an HSV-1 mutant with the MUC1/DF3 promoter regulating gamma(1) 34.5 expression will undergo further examination as a novel cancer therapy agent...
  88. ncbi Acinar cell carcinoma of the pancreas: an institutional series of resected patients and review of the current literature
    Akhil K Seth
    Department of Surgery, The Johns Hopkins Medical Institutions, 600 North Wolfe Street, Carnegie 683, Baltimore, MD 21287, USA
    J Gastrointest Surg 12:1061-7. 2008
    ..Acinar cell carcinoma (ACC) is a rare, malignant neoplasm with a generally poor prognosis. We report our institutional series of 14 patients with ACC to determine current guidelines for their evaluation and treatment...
  89. ncbi Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:490-8. 2004
    ..VR must be considered when selecting patients for balloon catheter-based APBI, because a minority of patients will have a lumpectomy cavity that exceeds the size limit of the current balloon device...
  90. ncbi Hepatic resection for colorectal metastases: the impact of surgical margin status on outcome
    George A Poultsides
    Department of Surgery, Johns Hopkins Medical Institutions, 600 North Wolfe Street, Baltimore, MD 21287, USA
    HPB (Oxford) 12:43-9. 2010
    ....
  91. ncbi Understanding surgical decision making in early hepatocellular carcinoma
    Hari Nathan
    The Johns Hopkins Hospital, 600 N Wolfe St, Harvey 611, Baltimore, MD 21287, USA
    J Clin Oncol 29:619-25. 2011
    ..We sought to quantify the impact of both clinical factors and surgeon specialty on surgical decision making in early HCC by using conjoint analysis...
  92. ncbi Predictors of survival after resection of early hepatocellular carcinoma
    Hari Nathan
    Department of Surgery, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ann Surg 249:799-805. 2009
    ..To identify clinicopathologic factors that predict survival following hepatectomy in patients with early hepatocellular carcinoma (HCC)...
  93. ncbi Hepatitis serology predicts tumor and liver-disease characteristics but not prognosis after resection of hepatocellular carcinoma
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    J Gastrointest Surg 8:794-804; discussion 804-5. 2004
    ..The prognosis after resection of HCC is influenced by tumor factors and liver disease, but not by HBV or HCV infection. The treatment for HCC should be dictated by the extent of underlying liver disease rather than by hepatitis serology...
  94. ncbi Echogenic appearance of colorectal liver metastases on intraoperative ultrasonography is associated with survival after hepatic resection
    Michelle L DeOliveira
    Department of Surgery, The Johns Hopkins University School of Medicine, 600 North Wolfe Street, Halsted 614, Baltimore, MD 22187 6681, USA
    J Gastrointest Surg 11:970-6; discussion 976. 2007
    ..4 vs isoechoic 37.4 vs hyperechoic 46.2%) (p < 0.05). Intraoperative ultrasound echogenicity should be considered a prognostic factor after hepatic resection of metastatic colorectal cancer...
  95. ncbi Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma
    Timothy M Pawlik
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA, and Department of Surgery, The University of Toronto, Princess Margaret Hospital, Canada
    Ann Surg Oncol 13:508-17. 2006
    ..We evaluated the long-term outcome of patients with operable RPS who were treated with protocol-based preoperative radiotherapy followed by complete surgical resection...
  96. ncbi Shifting from clinical to biologic indicators of prognosis after resection of hepatic colorectal metastases
    Timothy M Pawlik
    Department of Surgery, Johns Hopkins Hospital, Baltimore, MD 22187 6681, USA
    Curr Oncol Rep 9:193-201. 2007
    ..Moreover, tumor response to preoperative chemotherapy may also prove to be a useful predictor of outcome following liver resection for colorectal metastases...
  97. ncbi Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases
    Jean Nicolas Vauthey
    Department of Surgical Oncology, Unit 444, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 24:2065-72. 2006
    ..Chemotherapy before resection of hepatic colorectal metastases (CRM) may cause hepatic injury and affect postoperative outcome...
  98. ncbi Volume-based trends in thyroid surgery
    Christine G Gourin
    Department of Otolaryngology Head and Neck Surgery, The Johns Hopkins University, 601 N Caroline St, Ste 6260, Baltimore, MD 21287, USA
    Arch Otolaryngol Head Neck Surg 136:1191-8. 2010
    ..to characterize contemporary patterns of thyroid surgical care and variables associated with access to high-volume care...
  99. ncbi Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry
    Timothy M Pawlik
    Department of Surgical Oncology, Unit 444, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Breast Cancer Res Treat 89:149-57. 2005
    ..Proteomic screening techniques such as SELDI-MS analysis of NAF may be useful for breast cancer screening and diagnosis...
  100. ncbi Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients
    Timothy M Pawlik
    Department of Surgery, The University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
    Ann Surg Oncol 10:1059-69. 2003
    ..85, P =.04). CONCLUSIONS: Resection combined with RFA provides a surgical option to a group of patients with liver metastases who traditionally are unresectable, and may increase long-term survival...
  101. ncbi Making unresectable hepatic colorectal metastases resectable--does it work?
    Jean Nicolas Vauthey
    Department of Surgery, The University of Texas M D Anderson Cancer Center, Houston, 77030, USA
    Semin Oncol 32:S118-22. 2005
    ..Other approaches for patients with bilobar metastases include two-stage hepatic resection and the combined use of resection with radiofrequency ablation...